Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Hims & Hers Health Inc shares valued at $2,271,414 were purchased by Dudum Andrew on Jan 16 ’25. At $27.04 per share, Dudum Andrew acquired 83,994 shares.
Also, Okupe Oluyemi sold 11,581 shares, netting a total of over 283,083 in proceeds. Following the sale of shares at $24.44 each, the insider now holds 118,077 shares.
Before that, Chi Michael had sold 7,259 shares from its account. In a trade valued at $174,724, the Chief Commercial Officer traded Hims & Hers Health Inc shares for $24.07 each. Upon closing the transaction, the insider’s holdings decreased to 7,259 shares, worth approximately $5.41 million.
As published in a research note from Citigroup on January 10, 2025, Hims & Hers Health Inc [HIMS] has been rated down from a Neutral to a Sell and the price target has been revised to $25 from $24. Analysts at BTIG Research started covering the stock with ‘”a Buy”‘ outlook in a report released in early January. As of December 17, 2024, Morgan Stanley has initiated its “an Overweight” rating for HIMS. Earlier on November 14, 2024, BofA Securities downgraded its rating. Their new recommendation was “an Underperform” for HIMS stock which previously was a “a Buy”.
Analyzing HIMS Stock Performance
During the last five days, there has been a surge of approximately 8.59%. Over the course of the year, Hims & Hers Health Inc shares have jumped approximately 15.55%. Shares of the company reached a 52-week high of $28.81 on 01/07/25 and a 52-week low of $24.07 on 01/10/25. A 50-day SMA is recorded $27.21, while a 200-day SMA reached $20.15. Nevertheless, trading volume fell to 9.69 million shares from 10.51 million shares the previous day.
Support And Resistance Levels for Hims & Hers Health Inc (HIMS)
According to the 24-hour chart, there is a support level at 26.83, which, if violated, would cause prices to drop to 25.73. In the upper region, resistance lies at 28.86. The next price resistance is at 29.79. RSI (Relative Strength Index) is 53.04 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.92, which suggests the price will decrease in the coming days. Percent R is at 37.18%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
